CAS: 866460-33-5 - Setipiprant
Formula:C24H19FN2O3
InChI:InChI=1S/C24H19FN2O3/c25-16-8-9-21-19(12-16)20-13-26(11-10-22(20)27(21)14-23(28)29)24(30)18-7-3-5-15-4-1-2-6-17(15)18/h1-9,12H,10-11,13-14H2,(H,28,29)
InChI key:InChIKey=IHAXLPDVOWLUOS-UHFFFAOYSA-N
SMILES:O=C(O)CN1C=2C=CC(F)=CC2C3=C1CCN(C(=O)C4=CC=CC=5C=CC=CC54)C3
2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid
CAS:866460-33-5
Formula:
C24H19FN2O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
402.4177
Ref: IN-DA00GU6H
5mg | 87.00 € | ||
25mg | 187.00 € | ||
100mg | 545.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Setipiprant
CAS:866460-33-5
Setipiprant (ACT-129968) is an oral CRTH2 antagonist for asthma/allergy, targeting PGD2-induced inflammation (IC50: 6.0 nM).
Formula:
C24H19FN2O3
Purity:
99.16%
Color and Shape:
Solid
Molecular weight:
402.42
Ref: TM-T3520
10mg | 46.00 € | ||
25mg | 78.00 € | ||
50mg | 114.00 € | ||
100mg | 176.00 € | ||
200mg | 260.00 € | ||
1mL*10mM (DMSO) | 36.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Setipiprant(ACT-129968)
CAS:866460-33-5
Setipiprant is a CRTH2-selective antagonist, which has been shown to be effective in reducing the …
Formula:
C24H19FN2O3
Purity:
Min. 95%
Molecular weight:
402.42 g/mol
Ref: 3D-RJB46033
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025